BioCentury
ARTICLE | Company News

Applied Biosystems, Eppendorf deal

November 21, 2005 8:00 AM UTC

ABI granted Eppendorf worldwide rights to IP covering real-time thermal cyclers. Eppendorf may use the IP to manufacture and sell real-time PCR systems. ABI is eligible for royalties. ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article